Breaking News
Billions Of People Are Affected By This & They Don't Realize It | Dr. Robert Malone 2021
German Statisticians Find the Same Result in Germany as the UK...
Greenwald: The Cynical And Dangerous Weaponization Of The "White Supremacist" Label
Is Peak Social Media Already Behind Us?
Top Tech News
Check out the world's first FLOATING CITY! Flood-proof Oceanix - backed by the UN...
Wireless sensor grows into bone to monitor health data in real-time
One dollars worth of Melatonin reduces clotting, sepsis and death for Covid.
Budget Alpine home uses the sun as No-Bill climate-control
Fun Wind Turbine build that makes electricity
Taxi! To the Airport -- by Air, Please.
Getting Off the Electrical Grid - #SolutionsWatch
Rolls-Royce's electric plane hits 387 mph to lay claim as world's fastest
Diabolical -- How Digital ID Will Control Your Life
Lesson in joyful, smiling courage! Teacher Kath who lost all four limbs to sepsis and was...
DARPA Nucleic Technology Funded to Get Virus Response to 1-60 Days
The P3 teams are developing technologies to deliver antibodies using nucleic acid technology, and achieve sufficient serum concentrations of the antibodies for protection against the pathogen within three days after administration.
DARPA has programs for Pandemic Prevention Platform, Nucleic Acids On-Demand Worldwide (NOW), and PReemptive Expression of Protective Alleles and Response Elements (PREPARE) programs.
Nucleic Acids On-Demand Worldwide (NOW)
The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.